Posts In: Gubba Pharma In E News

Sun Pharma ensuring uninterrupted medicine supply to Sri Lanka: CFO

Ensuring uninterrupted supply of medicines to patients and doctors in Sri Lanka is among Sun Pharma’s top priorities. The company has been exploring several alternatives...

Continue Reading

Abbott Scores a Big Win in Diabetes

FDA cleared Abbott’s FreeStyle Libre 3, which is expected to be the most accurate and smallest continuous glucose monitoring sensor on the market.Just ahead of...

Continue Reading

“First Time In History”: Cancer Vanishes For Every Patient In Drug Trial

18 rectal cancer patients were given the same drug for six months and as a result of the treatment, cancer was completely obliterated in every...

Continue Reading

Official Humans of Gubba

“I come from one of the richest families in Orissa, we were brought up in a world of our own. We were taught to act...

Continue Reading

Biocon Biologics and Viatris Launch Abevmy their third oncology biosimilar in Canada

According to the companies, Abevmy follows the launch of their two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in...

Continue Reading

USFDA gives 5 observations to Glenmark Pharma for Goa facility

Drugmaker, Glenmark Pharma, has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with five observations after an inspection at...

Continue Reading

Torrent Pharma acquires 4 brands from Dr. Reddy’s Laboratories

The acquisition will strengthen Torrent’s positioning in gynaecology and urology therapyTorrent Pharmaceuticals Limited, announced acquisition of four brands in the therapeutic areas of gynaecology and...

Continue Reading

Alembic Pharmaceuticals rises after receiving USFDA nod for pulmonary fibrosis drug

Alembic Pharmaceuticals advanced 1.03% to Rs 768.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA)...

Continue Reading

Medley Pharma likely to be sold in deal worth Rs 5,000 crore

Medley Pharma, the privately held Mumbai-based company, is on the block. Drug majors like Cipla, Dr Reddy’s, KKR-backed JB Chemicals, and Torrent, along with marquee...

Continue Reading